Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
This is a clinical trial update for the CorEvitas Atopic Dermatitis Registry, a post-approval study evaluating safety and effectiveness of t…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
An international CorEvitas adolescent registry is being established to monitor safety and effectiveness of treatments for atopic dermatitis;…
-
EMA approval · 2026-02-06EMA Authorised: Cibinqo (abrocitinib) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Cibinqo (abrocitinib) for atopic dermatitis, with Pfizer Europe MA EEIG as the marketing authorizat…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: PALLAS Laser for Skin Diseases [NA]
A clinical trial update indicating recruitment for a study evaluating the PALLAS Laser for skin diseases, including vitiligo, psoriasis, alo…
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation [Phase 2, Phase 3]
A Phase 2/3 trial evaluating tralokinumab for atopic dermatitis sponsored by the University of Zurich has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Prospective Longitudinal Observational Research in Atopic Dermatitis
This is a prospective longitudinal observational study in atopic dermatitis, sponsored by the University of Zurich, that is currently recrui…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis [Phase 2]
A Phase II clinical trial evaluating ZL-82 tablets for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Phase III Study of GS101 Injection to Dupixent® [Phase 3]
A Phase 3 clinical trial evaluating GS101 Injection in combination with Dupixent for atopic dermatitis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
A completed clinical trial (TRAM) that tracks the microbiome in infants with atopic dermatitis and pediatric acute lymphoblastic leukemia, s…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Thera-Clean® Microbubbles System in Patients With Skin Diseases [EARLY_Phase 1]
Northwestern University is enrolling participants in an early-phase 1 trial of the Thera-Clean Microbubbles System for skin diseases, includ…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis [Phase 1]
A Phase 1 clinical trial evaluating the impact of Botox (onabotulinumtoxinA) on neuroimmune interactions in atopic dermatitis; the study is …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome [Phase 2]
A Phase 2 clinical trial is evaluating abrocitinib for atopic dermatitis and alopecia areata in individuals with Down syndrome and is curren…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Upadacitinib
AbbVie’s expanded access program for Upadacitinib is currently AVAILABLE for patients with Crohn's disease, ulcerative colitis, juvenile idi…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis [Phase 2]
A Phase II trial assessing the safety and efficacy of RSS0309 Ointment in adults with atopic dermatitis; the study is currently not recruiti…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 study evaluating the efficacy and safety of oral LW402 tablets in adults with moderate-to-severe atopic dermatitis; the trial is not…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
Milton S. Hershey Medical Center is conducting a study to assess whether the breast milk micro-transcriptome influences the development of a…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD) [Phase 1]
Phase 1 study of KT-621 in adults with atopic dermatitis reported safety, pharmacokinetics, pharmacodynamics, and early clinical activity.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) [Phase 2]
A Phase 2 pediatric trial (TRAPEDS 1) is evaluating tralokinumab monotherapy for moderate-to-severe atopic dermatitis in children; the study…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis [Phase 4]
A Phase 4 comparative study is evaluating Crisaborole versus Tacrolimus for atopic dermatitis. The trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
A real-world clinical trial update assessing disease activity in adolescents and adults with atopic dermatitis treated with oral upadacitini…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants. [Phase 1]
Phase 1 trial comparing CKD-706 with US- and EU-Dupixent (dupilumab) in healthy adult participants with atopic dermatitis, assessing pharmac…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema) [NA]
The UPDATE Trial, evaluating UVB phototherapy for atopic dermatitis/eczema, is currently active but not recruiting and is sponsored by Acade…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Cardamom and Topical Roseomonas in Atopic Dermatitis [Phase 2]
Phase 2 clinical trial investigating the use of Cardamom and topical Roseomonas for atopic dermatitis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective
This clinical trial update describes a real-world study examining the impact of Atopic Dermatitis on caregivers, with recruitment not yet st…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) [Phase 2]
A Phase 2 study to evaluate the efficacy of GX-03 in moderate-to-severe atopic dermatitis (eczema) is currently recruiting.